Abstract
Regular consumption of natural antioxidants reduces the risk of developing diseases. Aloin is one of the main active phenolic components of Aloe vera. The main disadvantage of aloin is its concentration limit of use that causes cell damage. One of the aims of this study was to investigate the antioxidant activity of aloin in the presence and absence of camel β-casein (β-CN) and its peptide fractions. The mixture of aloin,β-CN and peptides showed a very high antioxidant activity in a synergistic manner as compared to each component alone. The alpha (α)-glucosidase inhibitory activity of aloin was also investigated in the presence and absence of β-CN and its peptides. Aloin alone is a potent inhibitor of α-glucosidase. The α-glucosidase inhibitory activity of aloin is reduced in the presence of β-CN or its peptides. The combination of aloin and β-CN or its peptides makes a high antioxidant functional ingredient.
Keywords: Alpha (α)-Glucosidase, Aloe vera components, aloin, camel β-casein, hydrolysates, inhibitory action, natural antioxidants
Protein & Peptide Letters
Title:Synergic Study of α-Glucosidase Inhibitory Action of Aloin and its Antioxidant Activity with and without Camel β-Casein and its Peptides
Volume: 20 Issue: 5
Author(s): F. Ghamari, S. M. Ghaffari, M. Salami, F. Moosavi-Movahedi, F. Farivar, A. Johari, A. A. Saboury, J. M. Chobert, T. Haertle and A. A. Moosavi-Movahedi
Affiliation:
Keywords: Alpha (α)-Glucosidase, Aloe vera components, aloin, camel β-casein, hydrolysates, inhibitory action, natural antioxidants
Abstract: Regular consumption of natural antioxidants reduces the risk of developing diseases. Aloin is one of the main active phenolic components of Aloe vera. The main disadvantage of aloin is its concentration limit of use that causes cell damage. One of the aims of this study was to investigate the antioxidant activity of aloin in the presence and absence of camel β-casein (β-CN) and its peptide fractions. The mixture of aloin,β-CN and peptides showed a very high antioxidant activity in a synergistic manner as compared to each component alone. The alpha (α)-glucosidase inhibitory activity of aloin was also investigated in the presence and absence of β-CN and its peptides. Aloin alone is a potent inhibitor of α-glucosidase. The α-glucosidase inhibitory activity of aloin is reduced in the presence of β-CN or its peptides. The combination of aloin and β-CN or its peptides makes a high antioxidant functional ingredient.
Export Options
About this article
Cite this article as:
Ghamari F., M. Ghaffari S., Salami M., Moosavi-Movahedi F., Farivar F., Johari A., A. Saboury A., M. Chobert J., Haertle T. and A. Moosavi-Movahedi A., Synergic Study of α-Glucosidase Inhibitory Action of Aloin and its Antioxidant Activity with and without Camel β-Casein and its Peptides, Protein & Peptide Letters 2013; 20 (5) . https://dx.doi.org/10.2174/0929866511320050015
DOI https://dx.doi.org/10.2174/0929866511320050015 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lysophosphatidic Acid and Ischemic Stroke
Vascular Disease Prevention (Discontinued) Natriuretic Peptides in Coronary Disease With Non-ST Elevation: New Tools Ready for Clinical Application?
Recent Patents on Cardiovascular Drug Discovery Nitric Oxide and Dietary Factors: Part III Minerals, Vitamins and Other Dietary and Lifestyle Factors
Vascular Disease Prevention (Discontinued) Clinical Evaluation of Anti-Obesity Drugs
Current Drug Targets Novel Caffeic Acid Phenethyl Ester (Cape) Analogues as Inducers of Heme Oxygenase-1
Current Pharmaceutical Design Integrative Analysis of Whole-genome Expression Profiling and Regulatory Network Identifies Novel Biomarkers for Insulin Resistance in Leptin Receptor-deficient Mice
Medicinal Chemistry Differential Contribution of Clinical Amounts of Acetaldehyde to Skeletal and Cardiac Muscle Dysfunction in Alcoholic Myopathy
Current Pharmaceutical Design Oxidative Stress, Inflammation and Endothelial Biomarkers in Arterial Hypertension
Current Hypertension Reviews Hydrogen Sulfide-Based Therapies: Focus on H2S Releasing NSAIDs
Inflammation & Allergy - Drug Targets (Discontinued) Preface [Hot topic: Insulin Resistance and Impaired Coronary Endothelial Function (Guest Editor: Teruo Inoue)]
Current Drug Targets - Cardiovascular & Hematological Disorders Long-Term Effectiveness and Safety Outcomes in HIV-1-Infected Patients After a Median Time of 6 Years on Nevirapine
Current HIV Research Monitoring and Surveillance of Obesity in the United States
Current Nutrition & Food Science Mild Cognitive Impairment: Advantages of a Comprehensive Neuropsychological Assessment
Current Alzheimer Research Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence
Current Vascular Pharmacology FTIR Spectroscopy to Study Bioeffects of Static Magnetic Fields on Neuronal-like Cell Cultures
Current Metabolomics Novel Strategies for Preventing Diabetes and Obesity Complications with Natural Polyphenols
Current Medicinal Chemistry Decrease in Serum Levels of Adiponectin and Increase in 8-OHdG: a Culprit for Cognitive Impairment in the Elderly Patients with Type 2 Diabetes
Current Molecular Medicine Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Pharmacokinetic and Pharmacodynamic Variability: A Daunting Challenge in Drug Therapy
Current Drug Metabolism Sleep-Related Disorders, Diabetes and Obesity: Understanding the Facts
Current Respiratory Medicine Reviews